These observations suggest that PAR2-mediated smooth muscle activation, either directly or indirectly through LTC4 released from epithelial cells (71), may contribute to the smooth muscle hypertrophy and/or hyperplasia seen in patients with asthma. The gene discussed is F2RL1; the disease is asthma.